TSH receptor antagonizing tetrahydroquinoline compounds
AssigneeMerck Sharp & Dohme Corp.
InventorsWillem Frederik Johan Karstens, Paolo Giovanni Martino Conti, Cornelis Marius Timmers, Ralf Plate, Christianus Johannes Van Koppen
Life of this patent
Estimating the term…
Abstract
The present invention relates the use of a compound, a pharmaceutical composition, compounds and a kit for treating or preventing disorders in a mammal responsive to TSH receptor mediated pathways, including disorders such as hyperthyroidism, Graves' disease, Graves Ophthalmopathy, Graves' associated pretibial dermopathy, nodular goitre and thyroid cancer comprising administering to said mammal an effective amount of a tetrahydroquinoline compound of Formula (I) or an pharmaceutically acceptable salt thereof.
Claims4
A compound selected from the group consisting of
- 1) N-(1-Acetyl-4-methyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-2-phenoxy-acetamide, and
- 2) N-(1-Acetyl-4-methyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-3-thiophen-2-yl-propionamide.
A compound selected from the group consisting of
- 1) (1-Acetyl-2,2,4-trimethyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-carbamic acid 2-phenoxy-ethyl ester;
- 2) (1-Acetyl-7-dimethylamino-4-methyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-carbamic acid thiophen-2-ylmethyl ester;
- 3) (1-Acetyl-4-methyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-carbamic acid 1-methyl-cyclopropylmethyl ester;
- 4) (1-Acetyl-4-methyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-carbamic acid cyclobutylmethyl ester;
- 5) (1-Acetyl-4-methyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-carbamic acid (1R,2S,4S)-bicyclo[2.2.1]hept-2-yl ester;
- 6) (1-Acetyl-4-methyl-4-phenyl-1,2,3,4,4a,8a-hexahydro-quinolin-6-yl)-carbamic acid cyclopentyl ester;
- 7) (1-Acetyl-4-methyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-carbamic acid 3-chloro-4-fluoro-benzyl ester;
- 8) (+)-(1-Acetyl-4-methyl-4-phenyl-1,2,3,4,4a,8a-hexahydro-quinolin-6-yl)-carbamic acid cyclopentyl ester;
- and
- 9) (+)-(1-Acetyl-4-methyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-carbamic acid 3-chloro-4-fluoro-benzyl ester.
A compound selected from the group consisting of
- 1) 1-(1-Acetyl-4-methyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-3-(4-chloro-benzyl)-urea;
- 2) (+)-1-(1-Acetyl-4-methyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-3-(4-chloro-benzyl)-urea.
A compound selected from the group consisting of
- 1) Hexanoic acid (1-acetyl-2,2,4-trimethyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-amide;
- 2) 1-Methyl-1H-pyrrole-2-carboxylic acid (1-acetyl-2,2,4-trimethyl-4-phenyl-1,2,3,4-tetrahydro quinolin-6-yl)-amide;
- 3) Pyridine-2-carboxylic acid (1-acetyl-2,2,4-trimethyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-amide;
- 4) N-(1-Acetyl-2,2,4-trimethyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-3,4-dimethyl-benzamide;
- 5) (1-Acetyl-2,2,4-trimethyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-carbamic acid butyl ester;
- 6) 1-(1-Acetyl-2,2,4-trimethyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-3-cyclopentyl-urea;
- 7) Hexanoic acid [1-acetyl-4-(4-bromo-phenyl)-4-methyl-1,2,3,4-tetrahydro-quinolin-6-yl]-amide;
- 8) N-(1-Acetyl-4-methyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-3-(3-chloro-phenyl)-propionamide;
- 9) Hexanoic acid {1-acetyl-4-[4-(3-fluoro-pyridin-4-yl)-phenyl]-4-methyl-1,2,3,4-tetrahydro-quinolin-6-yl}-amide;
- 10) [4-(1-Acetyl-6-hexanoylamino-4-methyl-1,2,3,4-tetrahydro-quinolin-4-yl)-phenyl]-carbamic acid 3-chloro-benzyl ester;
- 11) [4-(1-Acetyl-6-hexanoylamino-4-methyl-1,2,3,4-tetrahydro-quinolin-4-yl)-phenyl]-carbamic acid methyl ester;
- 12) N-(1-Acetyl-7-dimethylamino-4-methyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-3-(4-chloro-phenyl)-propionamide;
- 13) 1-(1-Acetyl-7-dimethylamino-4-methyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-3-(2-methoxy-benzyl)-urea;
- 14) Biphenyl-4-carboxylic acid (1-acetyl-7-methoxy-2,2,4-trimethyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-amide;
- 15) Furan-2-carboxylic acid [1-acetyl-7-methoxy-4-(4-methoxy-phenyl)-2,2,4-trimethyl-1,2,3,4-tetrahydro-quinolin-6-yl]-amide;
- 16) Biphenyl-4-carboxylic acid [1-acetyl-4-(4-cyanomethoxy-phenyl)-2,2,4-trimethyl-1,2,3,4-tetrahydro-quinolin-6-yl]-amide;
- 17) Biphenyl-4-carboxylic acid {1-acetyl-2,2,4-trimethyl-4-[4-(pyridin-4-ylmethoxy)-phenyl]-1,2,3,4-tetrahydro-quinolin-6-yl}-amide;
- 18) [4-(1-Acetyl-6-hexanoylamino-4-methyl-1,2,3,4-tetrahydro-quinolin-4-yl)-phenyl]-carbamic acid furan-2-ylmethyl ester;
- 19) N-(1-Acetyl-2,2,4-trimethyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-3-(3-chloro -phenyl)-propionamide;
- 20) (1-Acetyl-4-methyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-carbamic acid 3-methyl-butyl ester;
- 21) (1-Acetyl-4-methyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-carbamic acid (R)-1,2-dimethyl-propyl ester;
- 22) N-(1-Acetyl-4-methyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-3-(3-trifluoromethyl-phenyl)-propionamide;
- 23) 5-Bromo-thiophene-2-carboxylic acid (1-acetyl-4-methyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-amide;
- 24) (+)-N-(1-Acetyl-2,2,4-trimethyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-3-(3-chloro-phenyl)-propionamide;
- 25) (+)-N-(1-Acetyl-4-methyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-3-(3-trifluoromethyl-phenyl)-propionamide;
- and
- 26) (+)-(1-Acetyl-4-methyl-4-phenyl-1,2,3,4,4a,8a-hexahydro-quinolin-6-yl)-carbamic acid cyclopentyl ester.
Dependencies are inferred from the claim text.